In addition, P/LP variants in the BARD1 and NBEAL1 genes were often found in patients with ER-negative BC, while variants in the ATM, BRCA2, and PALB2 genes prevailed in ER-positive BC carriers, although the differences were not statistically significant (Table S4, Figure 5a). This evidence concerns the gene ATM and breast cancer.